The company introduces a painless blood test chip device that combines microneedles and microfluidic technology. This innovative device simplifies at-home monitoring for chronic diseases, contributing to efficient healthcare service delivery, reduced resource pressures, and improved patient satisfaction.
| Cohorts | Biotech & Life Science |
|---|---|
| Fundraising Stage | Series Pre-A |
| Founder | Yu-Lung Hsieh |
| Region | Mainland China |